Hospital Raja Permaisuri Bainun
Ipoh, Perak, Malaysia
Government hospital in Ipoh
Hospital Raja Permaisuri Bainun, Jalan Raja Ashman Shah, 30450 Ipoh, Perak
About Hospital Raja Permaisuri Bainun
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
3
The George Institute
3
Celgene
2
Clinical Research Centre, Malaysia
2
Hoffmann-La Roche
2
Hospital Sultanah Bahiyah
2
Pfizer
2
University of Malaya
2
Boehringer Ingelheim
1
Gilead Sciences
1
Clinical Trials at Hospital Raja Permaisuri Bainun
During the past decade, Hospital Raja Permaisuri Bainun conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 13 clinical trials were completed, i.e. on
average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 9 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
2011-09-01
2014-06-01
Completed
323
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
2012-02-21
2019-08-22
Completed
605
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
2012-05-05
2021-07-23
Completed
503
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
2013-04-03
2019-02-20
Completed
219
Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
2013-10-01
2015-06-01
Terminated
180
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia
2016-05-02
2021-01-05
Completed
336
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials
sponsored, "The George Institute" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Clinical Research Centre, Malaysia"
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Raja Permaisuri Bainun"
#1 collaborator was "Hospital Queen Elizabeth, Malaysia" with 3 trials as a collaborator, "Kuala Lumpur General Hospital" with 3 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator and "Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were
collaborators in the rest 29 trials.
Clinical Trials Conditions at Hospital Raja Permaisuri Bainun
According to Clinical.Site data, the most researched conditions in "Hospital Raja Permaisuri Bainun" are
"Arthritis, Psoriatic" (4 trials), "COVID-19" (4 trials), "Depressive Disorder, Major" (4 trials), "Rheumatoid Arthritis" (3 trials) and "Anosmia" (2 trials). Many other conditions were trialed in "Hospital Raja Permaisuri Bainun" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Raja Permaisuri Bainun
Most popular intervention types in "Hospital Raja Permaisuri Bainun" are "Drug" (29 trials), "Other" (6 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Guselkumab" (5 trials), "Luspatercept" (2 trials), "Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances" (2 trials) and "SSRI/SNRI" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Raja Permaisuri Bainun
The vast majority of trials in "Hospital Raja Permaisuri Bainun" are
36 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hospital Raja Permaisuri Bainun
Currently, there are NaN active trials in "Hospital Raja Permaisuri Bainun".
undefined are not yet recruiting,
11 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Hospital Raja Permaisuri Bainun,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Raja Permaisuri Bainun, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 3 trials that are defined as “Not Applicable".